Carlos Tobón

The Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical <i>PSEN1</i> E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal‐dominant Alzheimer's disease, including a placebo‐treated noncarrier cohort

Pierre N. Tariot, Francisco Lopera, Jessica B. Langbaum et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2018 · 129 citations · Full text

Medicine, Neurology, Pharmacology +17

APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer’s disease

Jorge I. Vélez, Francisco Lopera, Diego Sepúlveda‐Falla et al. · Molecular Psychiatry · 2015 · 109 citations · Full text

Life Sciences, Genetics, Neurology +17

Resting-state EEG alpha/theta ratio related to neuropsychological test performance in Parkinson’s Disease

Alberto Jaramillo-Jiménez, Jazmín Ximena Suárez-Revelo, John Fredy Ochoa-Gómez et al. · Clinical Neurophysiology · 2021 · 42 citations

Life Sciences, Neurology, Neuroscience +15

Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial

Silvia Ríos‐Romenets, Francisco Lopera, Kaycee M. Sink et al. · Alzheimer s & Dementia · 2020 · 31 citations · Full text

Medicine, Neurology, Neuroscience +17

Spectral features of resting-state EEG in Parkinson's Disease: A multicenter study using functional data analysis

Alberto Jaramillo-Jiménez, Diego Tovar, Johann Alexis Ospina Galindez et al. · Clinical Neurophysiology · 2023 · 29 citations · Full text

Life Sciences, Neurology, Neuroscience +17